Abraham, Ninan
University of British Columbia
Therapeutic targeting of the IL-7Ra pathway in acute lymphoblastic leukemia |
2014/2015 : $66,668
2015/2016 : $66,666
2016/2017 : $66,666
|
Bally, Marcel
BC Cancer Agency (Vancouver)
Lipid-based nanoparticulate formulations of copper complexed diethyl-dithiocarbamate used alone and in combination with temozolomide and/or Irinophore C to treat glioblastoma multiforma |
2014/2015 : $100,000
2015/2016 : $100,000
|
Batada, Nizar
Ontario Institute for Cancer Research
DNA repair associated mutational signatures as biomarkers |
2014/2015 : $98,650
2015/2016 : $100,000
|
Blank, Volker
Lady Davis Institute
Novel regulatory pathways controlling hematopoietic stem cell fate |
2014/2015 : $100,000
2015/2016 : $91,810
|
Boutros, Paul
Ontario Institute for Cancer Research
Genomic characterization of Rb1+/+ retinoblastoma |
2014/2015 : $100,000
2015/2016 : $100,000
|
Buckstein, Rena
Sunnybrook Research Institute
The screening for MDS mutations in the aging population for early detection of disease |
2014/2015 : $94,650
2015/2016 : $97,590
|
Cypel, Marcelo
The Toronto Hospital (General Division) - UHN
Development of isolated lung perfusion for the treatment of cancer metastases to the lungs |
2014/2015 : $100,000
2015/2016 : $96,830
|
Dedhar, Shoukat
BC Cancer Agency (Vancouver)
Identification and development of novel anti-cancer agents targeting centrosome clustering |
2014/2015 : $93,112
2015/2016 : $93,112
|
Diorio, Caroline
Laval University
DNA methylation in normal breast tissue associated to risk of second contralateral breast cancer |
2014/2015 : $100,000
2015/2016 : $99,896
|
Dirks, Peter
Hospital for Sick Children
Wnt signalling control of glioblastoma stem cell fate |
2014/2015 : $99,715
2015/2016 : $98,563
|
Fradet, Vincent
Laval University
Phase II double-blind randomized controlled trial of concentrated omega-3 (mainly EPA) before prostatectomy evaluating the effects on prostate cancer proliferation, inflammation and quality of life. |
2014/2015 : $32,600
2015/2016 : $97,145
2016/2017 : $70,250
|
Gallouzi, Imed
McGill University
Role of stress granules in preventing cancer-induced muscle wasting |
2014/2015 : $98,537
2015/2016 : $98,537
|
Girardin, Stephen
University of Toronto
The role of NLRX1 in colorectal cancer and apoptosis |
2014/2015 : $95,000
2015/2016 : $95,000
|
Gotay, Carolyn
University of British Columbia
Increasing healthy outcomes for prostate cancer survivors: an innovative cooking class intervention feasibility study |
2014/2015 : $73,328
2015/2016 : $85,907
|
Harkness, Troy
University of Saskatchewan
Metformin and microarrays: an innovative approach to treating and monitoring drug resistant canine lymphoma |
2014/2015 : $78,832
2015/2016 : $86,168
|
Jones, Russell
McGill University
Investigating the role of the immune system in the pathology of LKB1-mediated tumourigenesis |
2014/2015 : $62,435
2015/2016 : $63,435
2016/2017 : $66,435
|
Jones, Steven
BC Cancer Agency (Vancouver)
Modulators of FBXL2 to induce degradation of oncogenes – an innovative therapeutic approach |
2014/2015 : $97,620
2015/2016 : $97,620
|
Joshua, Anthony
Ontario Cancer Institute/PMCC - UHN
The utility and relevance of exome sequence analysis and circulating tumour DNA in assessing tumour heterogeneity in BRAF mutant melanoma |
2014/2015 : $62,005
2015/2016 : $90,695
2016/2017 : $46,980
|
Kelley, Shana
University of Toronto
An integrated fluidic chip for exosome analysis |
2014/2015 : $100,000
2015/2016 : $100,000
|
Kerbel, Robert
Sunnybrook Research Institute
A strategy for developing models of spontaneous bone metastasis in mice |
2014/2015 : $89,000
2015/2016 : $89,000
|
Khokha, Rama
Ontario Cancer Institute/PMCC - UHN
Proteome analysis of the mammary epithelial hierarchy: normal and high-risk |
2014/2015 : $94,900
2015/2016 : $94,900
|
Kramer, Desre
Cancer Care Ontario
From awareness to behavioural change (A2B): exploring the impact of heightened awareness of workplace exposures in Sarnia and Sudbury |
2014/2015 : $97,768
2015/2016 : $99,065
|
Kung, Sam K.P.
University of Manitoba
A novel role of GM-CSF in evading immune surveillance of natural killer cells in breast cancer |
2014/2015 : $67,239
2015/2016 : $68,315
2016/2017 : $64,329
|
Lam, Wan
BC Cancer Research Centre
Development of organ specific immunomodulators for the treatment of lung cancer |
2014/2015 : $100,000
2015/2016 : $100,000
|
Mai, Sabine
University of Manitoba
Nuclear architecture in cancer |
2014/2015 : $99,999
2015/2016 : $98,211
|
Makrigiannis, Andrew
University of Ottawa
Innate immunosurveillance of breast cancer |
2014/2015 : $92,707
2015/2016 : $92,707
|
Mazroui, Rachid
Laval University
Role of heme-regulated kinase in chemoresistance |
2014/2015 : $78,000
2015/2016 : $78,000
|
Muller, William
McGill University
Targeting canonical Wnt/ß-catenin signalling in ErbB2 mammary tumour progression |
2014/2015 : $97,500
2015/2016 : $97,500
|
Nelson, Brad
BC Cancer Agency (Victoria)
How does the immune system contend with intratumoral heterogeneity? |
2014/2015 : $97,938
2015/2016 : $100,000
|
Nitz, Mark
University of Toronto
Mass cytometry probes to evaluate tumour hypoxia |
2014/2015 : $99,750
2015/2016 : $99,750
|
Park, Morag
McGill University
Gastric cancer, mechanisms for intervention |
2014/2015 : $100,000
2015/2016 : $100,000
|
Pause, Arnim
McGill University
Investigation of tumour suppressive mechanism of ESCRT-dependent receptor degradation |
2014/2015 : $100,000
2015/2016 : $100,000
|
Petrecca, Kevin
McGill University
Development of novel therapeutics to prevent brain cancer invasion |
2014/2015 : $86,500
2015/2016 : $84,000
|
Prive, Gilbert
Ontario Cancer Institute/PMCC - UHN
The function of LZTR-1 in glioblastoma |
2014/2015 : $61,667
2015/2016 : $63,255
2016/2017 : $64,831
|
Ruth, Thomas
BC Cancer Research Centre
Targeted alpha therapy with At-211 |
2014/2015 : $96,966
2015/2016 : $100,000
|
Sabiston, Catherine
University of Toronto
Connecting peers in motion: a dyadic lifestyle activity intervention for women diagnosed with cancer |
2014/2015 : $96,201
2015/2016 : $71,536
2016/2017 : $23,668
|
Shah, Sohrab
University of British Columbia
Building a bridge from the cancer genome to the cancer clinic with visual analytics |
2014/2015 : $99,663
2015/2016 : $100,000
|
Sinnett, Daniel
Hopital Sainte-Justine
Long noncoding RNAs deregulated in childhood acute lymphoblastic leukemia |
2014/2015 : $99,678
2015/2016 : $99,499
|
Steidl, Christian
BC Cancer Research Centre
Detection of genomic rearrangements in archival lymphoma tissues using targeted capture sequencing |
2014/2015 : $100,000
2015/2016 : $99,351
|
Tepass, Ulrich
University of Toronto
A new model to study the cell biology of epithelial to mesenchymal transition (EMT) |
2014/2015 : $69,500
2015/2016 : $64,500
2016/2017 : $64,500
|
Thomson, Axel
McGill University
Mediators of stromal androgen response in prostate cancer as new therapeutic interventions |
2014/2015 : $44,000
2015/2016 : $47,000
2016/2017 : $44,500
|
Trudel, Suzanne
Ontario Cancer Institute/PMCC - UHN
A companion study to a phase II clinical trial of sequential treatment with MEK followed by AKT inhibition for the treatment of relapsed multiple myeloma |
2014/2015 : $70,573
2015/2016 : $70,573
2016/2017 : $58,573
|
Veillette, Andre
IRCM - Institut de Recherches Cliniques de Montréal
Mouse models to understand mechanisms of action and toxicity of elotuzumab, a new treatment for multiple myeloma |
2014/2015 : $66,666
2015/2016 : $66,666
2016/2017 : $66,668
|
Watson, Peter
BC Cancer Research Centre
Inflammation and resistance to endocrine therapy in breast cancer |
2014/2015 : $96,708
2015/2016 : $96,708
|
Weber, Michael
The Research Institute of the McGill University Health Centre (RI-MUHC)
Bone scaffolds as delivery systems for local and controlled release of anti-resorptive in bone metastasis treatment |
2014/2015 : $99,745
2015/2016 : $99,965
|
Young, Edmond
University of Toronto
Accessible microfluidic technology for modeling breast cancer tumor microenvironments |
2014/2015 : $83,800
2015/2016 : $58,100
2016/2017 : $58,100
|